Matthews Judith M.
- SEC CIK
- 0001734033
No open-market purchases or sales filed in the past year.
Current role at each company
- ETON Eton Pharmaceuticals, Inc.Chief Financial Officeras of Aug 4, 2026
- ITRM Iterum Therapeutics plcChief Financial Officeras of Apr 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Matthews Judith M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ITRM Iterum Therapeutics plc
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2022 (view filing)7:12 PM ET | Mar 14 | 1 day | Matthews Judith M.Chief Financial Officer | SSale | −63.3K | $0.31 | −$19.6K | −49.2%65.3K after | Amended |